Craig Hartman

Craig Hartman is a seasoned CFO with global experience in Fortune 100 and private equity backed medical device, pharmaceutical, and healthcare services companies.

He excels as a skilled strategic business partner and advisor to the CEO, management team, and board members, driving disciplined growth and transformation while delivering improved operational and financial performance.

Craig Hartman's expertise encompasses financial operations leadership, including FP&A, accounting, global treasury, tax, audit, compliance, capital investments, M&A, risk management, debt and equity financings.

With eight years of experience as a Global Investor Relations Officer, he has a strong track record in managing quarterly SEC reporting, earnings releases, international roadshows, conference presentations, annual analyst meetings, and maintaining relationships with institutional investors and analysts.

Craig Hartman's core competencies include strategic partnership and advisory roles, cash management, debt financings, equity issuance, leadership in forecasting and planning, board and investor relationships, team building, revenue cycle management, GAAP and SEC reporting, IPO readiness, business development, Medicare and Medicaid reimbursement knowledge, consumer marketing, and customer acquisition.

He holds a Master's in Business Administration with a concentration in Finance from the University of Notre Dame - Mendoza College of Business, a BA in Economics from DePauw University, and has studied at Albert-Ludwigs-Universität Freiburg im Breisgau.

Craig Hartman has held key roles such as CFO, Transformation Leader, and Management Consultant at Alvarez & Marsal, as well as CFO positions in portfolio companies at Water Street Healthcare Partners and New Enterprise Associates (NEA).

His previous experience includes serving as Vice President of Investor Relations at CVS Health and in finance management roles at Eli Lilly and Company across R&D, global treasury, and investor relations.